Focal therapy of prostate cancer: patient selection, current limitations, and perspective of introduction into clinical practice

Focal therapy is a promising option for localized prostate cancer treatment in low and intermediate risk patients. The combination of minimal invasiveness, disease control and the possibility of re-treatment in case of recurrence have significantly increased interest in focal therapy. However, before the final introduction of focal therapy into clinical practice, a number of significant limitations have yet to be overcome, such as patient selection, visualization of target, the choice of the treatment modality and the surgery planning, as well as the development  of a follow-up protocol. Studies have shown that focal therapy has minimal impact on the quality of life, but its oncological effectiveness has yet to be evaluated in comparison with radical methods of treatment.

focal therapy, prostate cancer, patient selection, oncological efficacy, quality of life

1. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2017. 250 с. [Malignant tumors in Russia in 2015 (morbidity and fatality). Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2017. 250 p. (In Russ.)].

2. Murphy D.G., Walton T.J., Connolly S., Costello A.J. Focal therapy for localised prostate cancer: are we asking the correct research questions? BJU Int 2012;109(1):1–3. DOI: 10.1111/j.1464-410X.2011.10804.x. PMID: 22151749.

3. Bott S.R., Ahmed H.U., Hindley R.G. et al. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010;106(11): 1607–11. DOI: 10.1111/j.1464-410X.2010.09436.x. PMID: 20553262.

4. Futterer J.J., Briganti A., De Visschere P. et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 2015;68(6):1045–53. DOI: 10.1016/j.eururo.2015.01.013. PMID: 25656808.

5. Liu W., Laitinen S., Khan S. et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15(5):559–65. DOI: 10.1038/nm.1944. PMID: 19363497.

6. Ahmed H.U. The index lesion and the origin of prostate cancer. N Engl J Med 2009;361(17):1704–6. DOI: 10.1056/NEJMcibr0905562. PMID: 19846858.

7. Boutros P.C., Fraser M., Harding N.J. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat Genet 2015;47(7):736–45. DOI: 10.1038/ng.3315. PMID: 26005866.

8. Sabel M.S., Nehs M.A., Su G. et al. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 2005;90(1):97–104. DOI: 10.1007/s10549-004-3289-1. PMID: 15770533.

9. Onik G.M., Narayan P., Vaughan D. et al. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urol 2002;60(1):109–14. PMID: 12100934.

10. Ouzzane A., Betrouni N., Valerio M. et al. Focal therapy as primary treatment for localized prostate cancer: definition, needs and future. Future Oncol 2017;13(8): 727–41. DOI: 10.2217/fon-2016-0229. PMID: 27882770.

11. Bass E.J., Ahmed H.U. Focal therapy in prostate cancer: a review of seven common controversies. Cancer Treat Rev 2016;51:27–34. DOI: 10.1016/j.ctrv.2016.07.004. PMID: 27846402.

12. Mottet N., Bellmunt J., Briers E. et al. EAU–ESTRO–ESUR–SIOG guidelines on prostate cancer. Netherlands: European Association of Urology, 2017. 146 р.

13. Valerio M., Cerantola Y., Eggener S.E. et al. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol 2017;71(1):17–34. DOI: 10.1016/j.eururo.2016.08.044. PMID: 27595377.

14. Abdollah F., Scattoni V., Raber M. et al. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU Int 2011;108(3):366–71. DOI: 10.1111/j.1464-410X.2010.09876.x. PMID: 21087451.

15. Singh P.B., Anele C., Dalton E. et al. Prostate cancer tumour features on template prostate-mapping biopsies: implications for focal therapy. Eur Urol 2014;66(1):12–9. DOI: 10.1016/j.eururo.2013.09.045. PMID: 24207133.

16. Tran M., Thompson J., Böhm M. et al. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy. BJU Int 2016;117(1):48–54. DOI: 10.1111/bju.13090. PMID: 25682968.

17. Tay K.J., Scheltema M.J., Ahmed H.U. et al. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. Prostate Cancer Prostatic Dis 2017;20(3):294–9. DOI: 10.1038/pcan.2017.8. PMID: 28349978.

18. Moore C.M., Azzouzi A.R., Barret E. et al. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy. BJU Int 2015;116(6):888–96. DOI: 10.1111/bju.12816. PMID: 24841929.

19. Azzouzi A.R., Vincendeau S., Barret E. et al. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol 2017;18(2):181–91. DOI: 10.1016/S1470-2045(16)30661-1. PMID: 28007457.

20. Villers A., Flamand V., Arquímedes R.C. et al. Robot-assisted partial prostatectomy for anterior prostate cancer: a step-by-step guide. BJU Int 2017;119(6):968–74. DOI: 10.1111/bju.13785. PMID: 28111893.

21. Говоров А.В., Васильев А.О., Ковыли- на М.В. и др. Эффективность криовоздействия в зависимости от количественных и качественных режимов замораживания. Экспериментальная и клиническая урология 2015;(1):24–8. [Govorov A.V., Vasilyev A.O., Kovylina M.V. et al. Efficacy of cryodestruction depending on the qualitative and quantitative settings of the freezing and thawing. Experimental’naya i klinicheskaya urologiya = Experimental and Clinical Urology 2015;(1):24–8. (In Russ.)].

22. Жердев А.А., Шакуров А.В., Пушка- рев А.В. и др. Исследование характеристик криозондов при различных режимах работы. Медицинская техника 2016;(5):41–4. [Zherdev A.A., Shakurov A.V., Pushkarev A.V. et al. Investigation of the characteristics of cryoprobes under various operating conditions. Meditsinskaya tekhnika = Medical Equipment 2016;(5):41–4. (In Russ.)]

23. Васильев А.О., Говоров А.В., Пушка- рев А.В. и др. Теплофизическое моделирование криохирургической операции на примере рака предстательной железы. Технологии живых систем 2014;11(4):47–53. [Vasilyev A.O., Govorov A.V., Pushkarev A.V. et al. Thermophysical modeling of cryosurgical surgery using prostate cancer as an example. Tekhnologii zhivykh system = Technologies of Living Systems 2014;11(4):47–53. (In Russ.)].

24. Zherdev A.A., Shakurov A.V., Pushkarev A.V. et al. Measurement of characteristics of cryoprobes under different operation modes. Biomedical Engineering 2017;50(5):344–7. DOI: 10.1007/s10527-017-9652-4.

25. Бурков И.А., Пушкарев А.В., Цыга- нов Д.И. и др. Исследование температурного распределения на рабочей поверхности малоинвазивного криозонда. Автоматизация. Современные технологии 2015;(9):23–5. [Burkov I.A., Pushkarev A.V., Tsiganov D.I. et al. Investigation of the temperature distribution on the working surface of a minimally invasive cryoprobe. Avtomatizatsiya. Sovremennye tekhnologii = Automation. Modern Technologies 2015;(9):23–5. (In Russ)].

26. Пушкарев А.В., Васильев А.О., Шептунов С.А. и др. Исследование факторов повреждения биотканей для создания криохирургического оборудования. Известия высших учебных заведений. Поволжский регион. Медицинские нау ки 2016;4(40):122–34. [Pushkarev A.V., Vasilyev A.O., Sheptunov S.A. et al. Investigation of factors of biotissue damages for creation of cryosurgical equipment. Izvestiya vysshikh uchebnykh zavedeniy. Povolzhskiy region. Meditsiskie nauki = News of Higher Educational Institutions. The Volga Region. Medical Sciences 2016;4(40):122–34. (In Russ.)].

27. Жердев А.А., Цыганов Д.И., Шакуров А.В. и др. Экспериментальное исследование тепловых характеристик малоинвазивных криозондов при различной мощности охлаждения. Медицинская техника 2017;5(305):15–8. [Zherdev A.A., Tsiganov D.I., Shakurov A.V. Experimental study of the thermal characteristics of minimally invasive cryoprobes at different cooling capacities. Meditsinskaya Tekhnika = Medical Equipment 2017;5(305):15–8. (In Russ.)].